Recent research suggest that increased activity of NLRP3 contributes to the development and progression of epilepsy [68,70,71,73,74,75,117]; hence, inhibiting the activity of NLRP3 may reduce inflammation-caused epileptic injuries and potentially improve symptoms [89]. Here, NLRP3 is linked to epilepsy.